These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 18976163

  • 1. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.
    Weinhaeusel A, Scheuba C, Lauss M, Kriegner A, Kaserer K, Vierlinger K, Haas OA, Niederle B.
    Thyroid; 2008 Dec; 18(12):1269-76. PubMed ID: 18976163
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?
    Baumgartner-Parzer SM, Lang R, Wagner L, Heinze G, Niederle B, Kaserer K, Waldhäusl W, Vierhapper H.
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6232-6. PubMed ID: 16118333
    [Abstract] [Full Text] [Related]

  • 3. Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
    Cardot-Bauters C, Leteurtre E, Leclerc L, Vantyghem MC, Do Cao C, Wemeau JL, d'Herbomez M, Carnaille B, Barbu V, Pinson S, Pigny P, Groupe d'Etude des Tumeurs Endocrines (GTE).
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):506-10. PubMed ID: 18331611
    [Abstract] [Full Text] [Related]

  • 4. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
    Frank-Raue K, Döhring J, Scheumann G, Rondot S, Lorenz A, Schulze E, Dralle H, Raue F, Leidig-Bruckner G.
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.
    Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vierhapper H, Haas OA, Niederle B.
    Am J Surg Pathol; 1998 Jun; 22(6):722-8. PubMed ID: 9630179
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F, Ramundo V, Chiofalo MG, Severino R, Paciolla I, Pezzullo L, Lombardi G, Colao A, Faggiano A.
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [Abstract] [Full Text] [Related]

  • 8. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
    Scheuba C, Kaserer K, Moritz A, Drosten R, Vierhapper H, Bieglmayer C, Haas OA, Niederle B.
    Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
    [Abstract] [Full Text] [Related]

  • 9. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
    Guyétant S, Josselin N, Savagner F, Rohmer V, Michalak S, Saint-André JP.
    Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
    [Abstract] [Full Text] [Related]

  • 10. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
    Niccoli-Sire P, Murat A, Rohmer V, Franc S, Chabrier G, Baldet L, Maes B, Savagner F, Giraud S, Bezieau S, Kottler ML, Morange S, Conte-Devolx B, French Calcitonin Tumors Group (GETC).
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
    [Abstract] [Full Text] [Related]

  • 11. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
    Machens A, Lorenz K, Dralle H.
    Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
    [Abstract] [Full Text] [Related]

  • 12. Medullary thyroid carcinoma: long-term outcomes of surgical treatment.
    Abraham DT, Low TH, Messina M, Jackson N, Gill A, Chou AS, Delbridge L, Learoyd D, Robinson BG, Sidhu S, Sywak M.
    Ann Surg Oncol; 2011 Jan; 18(1):219-25. PubMed ID: 20878247
    [Abstract] [Full Text] [Related]

  • 13. Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation.
    Shifrin AL, Ogilvie JB, Stang MT, Fay AM, Kuo YH, Matulewicz T, Xenachis CZ, Vernick JJ.
    Surgery; 2010 Dec; 148(6):1274-80; discussion 1280-1. PubMed ID: 21134561
    [Abstract] [Full Text] [Related]

  • 14. [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].
    Ting S, Synoracki S, Schmid KW.
    Pathologe; 2015 May; 36(3):246-53. PubMed ID: 25898937
    [Abstract] [Full Text] [Related]

  • 15. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
    Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A.
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
    [Abstract] [Full Text] [Related]

  • 16. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry JF.
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [Abstract] [Full Text] [Related]

  • 17. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R, Holzhausen HJ, Gimm O, Dralle H, Rath FW.
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [Abstract] [Full Text] [Related]

  • 18. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
    Zhao JQ, Guo L, Qi XP, Chen ZG, Wang KJ, Lou JL, Yu XH, Cheng J, Jin HY, Li XL, Ying RB, Zhang XN.
    Zhonghua Yi Xue Za Zhi; 2013 Feb 05; 93(6):440-4. PubMed ID: 23660264
    [Abstract] [Full Text] [Related]

  • 19. Thyroid carcinomas involving follicular and parafollicular C cells: seventeen cases with characterization of RET oncogenic activation.
    Vantyghem MC, Pigny P, Leteurtre E, Leclerc L, Bauters C, Douillard C, D'Herbomez M, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M.
    Thyroid; 2004 Oct 05; 14(10):842-7. PubMed ID: 15588381
    [Abstract] [Full Text] [Related]

  • 20. Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.
    Gursoy A, Erdogan MF, Erdogan G.
    J Endocrinol Invest; 2006 Nov 05; 29(10):858-62. PubMed ID: 17185892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.